CTXR Financial Statements

Balance sheet, income statement, cash flow, and dividends for Citius Pharmaceuticals Inc (CTXR).


$90.47M Market Cap.

As of 12/27/2024 5:00 PM ET (MRY) • Disclaimer

CTXR Market Cap. (MRY)


CTXR Shares Outstanding (MRY)


CTXR Assets (MRY)


Total Assets

$116.65M

Total Liabilities

$42.55M

Total Investments

$0

CTXR Income (MRY)


Revenue

$0

Net Income

-$39.14M

Operating Expense

$42.00M

CTXR Cash Flow (MRY)


CF Operations

-$28.20M

CF Investing

-$5.00M

CF Financing

$9.97M

CTXR Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

CTXR Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$116,651,751 (12.59%)

$103,611,150 (-9.11%)

$113,999,302 (-19.96%)

$142,429,059 (225.38%)

Assets Current

$14,220,646 (-58.63%)

$34,370,434 (-22.87%)

$44,564,270 (-38.80%)

$72,814,350 (420.77%)

Assets Non-Current

$102,431,105 (47.93%)

$69,240,716 (-0.28%)

$69,435,032 (-0.26%)

$69,614,709 (133.67%)

Goodwill & Intangible Assets

$9,346,796 (0.00%)

$9,346,796 (0.00%)

$9,346,796 (0.00%)

$9,346,796 (0.00%)

Shareholders Equity

$70,077,450 (-22.85%)

$90,831,108 (-11.67%)

$102,825,865 (-22.21%)

$132,182,353 (292.57%)

Property Plant & Equipment Net

$246,247 (-45.98%)

$455,858 (-29.89%)

$650,174 (-21.65%)

$829,851 (-15.99%)

Cash & Equivalents

$3,289,942 (-87.59%)

$26,518,990 (-36.48%)

$41,749,752 (-40.45%)

$70,111,008 (403.79%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$8,268,766 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$33,327,211 (1038.48%)

$2,927,334 (151.19%)

$1,165,378 (-8.75%)

$1,277,095 (-31.20%)

Accumulated Retained Earnings (Deficit)

-$201,370,218 (-24.13%)

-$162,231,379 (-25.09%)

-$129,688,467 (-35.02%)

-$96,047,821 (-36.06%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$6,713,800 (9.38%)

$6,137,800 (10.36%)

$5,561,800 (11.55%)

$4,985,800 (0.00%)

Total Debt

$262,865 (-45.38%)

$481,245 (-29.04%)

$678,234 (-20.72%)

$855,471 (-36.73%)

Debt Current

$241,547 (10.61%)

$218,380 (10.86%)

$196,989 (11.14%)

$177,237 (-46.61%)

Debt Non-Current

$21,318 (-91.89%)

$262,865 (-45.38%)

$481,245 (-29.04%)

$678,234 (-33.51%)

Total Liabilities

$42,549,921 (249.35%)

$12,179,662 (15.20%)

$10,573,057 (9.61%)

$9,646,326 (-4.52%)

Liabilities Current

$35,814,803 (519.74%)

$5,778,997 (27.57%)

$4,530,012 (13.75%)

$3,982,292 (-2.80%)

Liabilities Non-Current

$6,735,118 (5.23%)

$6,400,665 (5.92%)

$6,043,045 (6.69%)

$5,664,034 (-5.69%)

CTXR Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$18,249,402 (19.31%)

$15,295,584 (30.12%)

$11,754,609 (19.50%)

$9,836,412 (21.52%)

Research & Development Expense

$11,906,601 (-19.66%)

$14,819,729 (-16.06%)

$17,655,482 (44.24%)

$12,240,503 (38.89%)

Operating Expenses

$41,995,681 (14.33%)

$36,732,018 (10.25%)

$33,316,045 (41.58%)

$23,531,894 (32.87%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$10,839 (-30.84%)

Income Tax Expense

$576,000 (0.00%)

$576,000 (0.00%)

$576,000 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$39,425,839 (-21.15%)

-$32,542,912 (3.26%)

-$33,640,646 (-45.92%)

-$23,054,434 (-31.38%)

Net Income to Non-Controlling Interests

-$287,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$39,138,839 (-20.27%)

-$32,542,912 (3.26%)

-$33,640,646 (-45.92%)

-$23,054,434 (-31.38%)

Preferred Dividends Income Statement Impact

$1,047,312 (-9.02%)

$1,151,208 (0%)

$0 (0%)

$1,450,876 (0%)

Net Income Common Stock

-$40,186,151 (-19.27%)

-$33,694,120 (-0.16%)

-$33,640,646 (-37.28%)

-$24,505,310 (-39.65%)

Weighted Average Shares

$6,726,999 (-95.55%)

$151,294,729 (3.57%)

$146,082,399 (34.52%)

$108,599,080 (177.28%)

Weighted Average Shares Diluted

$6,726,999 (-95.55%)

$151,294,729 (3.57%)

$146,082,399 (34.52%)

$108,599,080 (177.28%)

Earning Before Interest & Taxes (EBIT)

-$38,562,839 (-20.63%)

-$31,966,912 (3.32%)

-$33,064,646 (-43.49%)

-$23,043,595 (-31.43%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$41,995,681 (-14.33%)

-$36,732,018 (-10.25%)

-$33,316,045 (-41.58%)

-$23,531,894 (-32.87%)

CTXR Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$5,000,000 (0%)

$0 (0%)

$0 (0%)

-$40,006,938 (-2184877.50%)

Net Cash Flow from Financing

$9,972,327 (-27.89%)

$13,829,450 (0%)

$0 (0%)

$120,470,550 (426.11%)

Net Cash Flow from Operations

-$28,201,375 (2.96%)

-$29,060,212 (-2.46%)

-$28,361,256 (-16.95%)

-$24,250,414 (-43.23%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$23,229,048 (-52.51%)

-$15,230,762 (46.30%)

-$28,361,256 (-150.45%)

$56,213,198 (842.23%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$5,000,000 (0%)

$0 (0%)

$0 (0%)

-$6,938 (-278.92%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

-$172,970 (-205.10%)

Issuance (Purchase) of Equity Shares

$13,803,684 (-0.19%)

$13,829,450 (0%)

$0 (0%)

$120,643,020 (430.68%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$12,123,854 (80.45%)

$6,718,705 (56.83%)

$4,284,158 (181.30%)

$1,522,979 (14.34%)

Depreciation Amortization & Accretion

$209,611 (7.87%)

$194,316 (8.15%)

$179,677 (8.98%)

$164,868 (8.21%)

CTXR Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-50.30% (-41.69%)

-35.50% (-19.93%)

-29.60% (-26.50%)

-23.40% (64.92%)

Return on Average Assets (ROAA)

-40.00% (-27.80%)

-31.30% (-16.36%)

-26.90% (-25.70%)

-21.40% (59.24%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-58.90% (-13.71%)

-51.80% (8.48%)

-56.60% (27.44%)

-78.00% (18.92%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.1 (32.63%)

-3.11 (40.87%)

-5.26 (40.39%)

-8.83 (-281.91%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

1.29 (7.85%)

1.2 (-30.41%)

1.72 (-23.28%)

2.24 (30.81%)

Debt to Equity Ratio (D/E)

0.61 (352.99%)

0.13 (30.10%)

0.1 (41.10%)

0.07 (-75.67%)

Earnings Per Share (EPS)

-5.97 (-2613.64%)

-0.22 (4.35%)

-0.23 (0.00%)

-0.23 (48.89%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-4.94 (-2470.83%)

-0.19 (1.03%)

-0.19 (13.00%)

-0.22 (48.38%)

Book Value Per Share (BVPS)

10.42 (1636.17%)

0.6 (-14.77%)

0.7 (-42.15%)

1.22 (41.51%)

Tangible Assets Book Value Per Share (TABVPS)

15.95 (2460.35%)

0.62 (-12.99%)

0.72 (-41.55%)

1.23 (39.36%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (0.00%)

-2 (50.00%)

-4 (50.00%)

-8 (-166.67%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.9 (20.54%)

-2.39 (39.29%)

-3.94 (50.43%)

-7.94 (-173.30%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

0.4 (-93.32%)

5.95 (-39.55%)

9.84 (-46.20%)

18.29 (435.75%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$33,201,375 (-14.25%)

-$29,060,212 (-2.46%)

-$28,361,256 (-16.92%)

-$24,257,352 (-43.26%)

Enterprise Value (EV)

$72,841,896 (-4.07%)

$75,935,267 (-41.34%)

$129,459,381 (-28.75%)

$181,698,111 (259.73%)

Earnings Before Tax (EBT)

-$38,562,839 (-20.63%)

-$31,966,912 (3.32%)

-$33,064,646 (-43.42%)

-$23,054,434 (-31.38%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$38,353,228 (-20.71%)

-$31,772,596 (3.38%)

-$32,884,969 (-43.74%)

-$22,878,727 (-31.64%)

Invested Capital

$68,463,075 (9.63%)

$62,447,612 (5.75%)

$59,050,976 (-1.33%)

$59,844,434 (236.87%)

Working Capital

-$21,594,157 (-175.53%)

$28,591,437 (-28.58%)

$40,034,258 (-41.84%)

$68,832,058 (596.34%)

Tangible Asset Value

$107,304,955 (13.83%)

$94,264,354 (-9.93%)

$104,652,506 (-21.36%)

$133,082,263 (286.57%)

Market Capitalization

$90,471,139 (-16.79%)

$108,722,277 (-38.51%)

$176,816,852 (-40.33%)

$296,338,241 (413.63%)

Average Equity

$79,965,544 (-15.86%)

$95,042,584 (-16.28%)

$113,528,665 (8.32%)

$104,806,543 (298.38%)

Average Assets

$100,463,380 (-6.54%)

$107,490,508 (-13.94%)

$124,904,286 (8.85%)

$114,750,025 (243.44%)

Invested Capital Average

$65,478,214 (6.20%)

$61,654,385 (5.49%)

$58,443,648 (97.91%)

$29,530,432 (62.02%)

Shares

7,229,016 (-95.45%)

158,857,798 (8.71%)

146,129,630 (0.10%)

145,979,429 (163.14%)